Followers | 78 |
Posts | 2609 |
Boards Moderated | 1 |
Alias Born | 12/04/2020 |
Wednesday, June 08, 2022 11:25:14 PM
What I want is a larger, more cash-rich company to take a piece of the pie to get Clone 3 through clinical trials with a swiftness. A merger or buyout could be great, too. But considering that Hicks wants to interview Chandra and Co. AFTER the NDA is lifted tells me that a buyout is not likely, since there would be no reason to interview anyone from ENZC after that, as they are just taking money to walk away and are no longer relevant to the future of the company.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
FEATURED Element79 Gold Corp. Reports Significant Progress in Community Relations and Development Efforts in Chachas, Peru • Oct 9, 2024 10:30 AM
Unitronix Corp Launches Share Buyback Initiative • UTRX • Oct 9, 2024 9:10 AM
BASANITE INDUSTRIES, LLC RECEIVES U.S. PATENT FOR ITS BASAFLEX™ BASALT FIBER COMPOSITE REBAR AND METHOD OF MANUFACTURING • BASA • Oct 9, 2024 7:30 AM
BNCM COMPLETES MERGER WITH DELEX HEALTHCARE • BNCM • Oct 8, 2024 9:54 AM
CBD Life Sciences, Inc. (CBDL) Reaches Unprecedented Heights With Explosive Growth and Strategic Expansion in 2024 • CBDL • Oct 8, 2024 8:00 AM
Unitronix Corp. to Invest $3 Million in USA Unity Coin Project • UTRX • Oct 7, 2024 7:08 AM